Sanofi Total Shareholders Equity 2011-2026 | SNY

Annual Total Shareholders Equity Sanofi

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	63.1 B	59.1 B	59 B	58.2 B	57.7 B	58.2 B	-	-	-	-

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
63.1 B	57.7 B	59.2 B

Quarterly Total Shareholders Equity Sanofi

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	69 B	-	63.4 B	-	63.3 B	-	63.5 B	-	59.2 B	-	56.5 B	-	59 B	-	-	-	58.2 B	-	-	-	57.7 B	-	-	-	58.2 B	-	-	-	56.3 B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in EUR currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
69 B	56.3 B	60.4 B

Total Shareholders Equity of other stocks in the Biotechnology industry

Issuer	Total Shareholders Equity	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	621 M	-	2.43 %	$ 254 M	Germany
Amphastar Pharmaceuticals AMPH	789 M	$ 21.66	1.14 %	$ 1.01 B	USA
I-Mab IMAB	1.72 B	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	715 M	-	-	$ 1.01 B	USA
Midatech Pharma plc MTP	6.72 M	-	-18.52 %	$ 27.3 M	Britain
Aptorum Group Limited APM	23.1 M	$ 0.9	-0.2 %	$ 6.62 M	China
Biophytis SA BPTS	2.27 M	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	-16.2 M	-	2.54 %	$ 160 B	France
ACADIA Pharmaceuticals ACAD	733 M	$ 22.33	1.66 %	$ 3.7 B	USA
Esperion Therapeutics ESPR	-302 M	$ 1.94	1.31 %	$ 403 M	USA
Advaxis ADXS	-24.4 M	-	-9.65 %	$ 45.9 M	USA
Galectin Therapeutics GALT	-128 M	$ 2.38	2.33 %	$ 152 M	USA
AIkido Pharma AIKI	69.4 M	-	1.93 %	$ 17.4 M	USA
Greenwich LifeSciences GLSI	2.53 M	$ 24.07	-0.58 %	$ 313 M	USA
Heron Therapeutics HRTX	14.3 M	$ 1.18	-0.84 %	$ 197 M	USA
ImmuCell Corporation ICCC	27.1 M	$ 8.26	-1.07 %	$ 74.6 M	USA
Akouos AKUS	234 M	-	0.23 %	$ 488 M	USA
InflaRx N.V. IFRX	77.9 M	$ 1.61	8.78 %	$ 152 M	Germany
Allakos ALLK	169 M	-	-	$ 28.6 M	USA
AlloVir ALVR	78.8 M	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	3.36 M	-	-11.43 %	$ 502 K	USA
Innate Pharma S.A. IPHA	156 M	$ 1.39	0.72 %	$ 235 M	France
Applied Molecular Transport AMTI	60.8 M	-	-	$ 10.1 M	USA
Inventiva S.A. IVA	111 M	$ 5.11	-0.78 %	$ 138 M	France
Jaguar Health JAGX	-18.7 M	$ 0.29	-25.25 %	$ 676 K	USA
Brainstorm Cell Therapeutics BCLI	-9.98 M	-	-2.5 %	$ 5.88 M	USA
Applied Therapeutics APLT	-17.1 M	-	-	$ 8.42 M	USA
Aptinyx APTX	38.3 M	-	-39.0 %	$ 4.57 M	USA
AgeX Therapeutics AGE	-37 K	-	-10.17 %	$ 12.2 K	USA
Aravive ARAV	10.7 M	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	-24.2 M	-	17.91 %	$ 11.1 M	USA
KalVista Pharmaceuticals KALV	-2.71 M	$ 19.09	-2.75 %	$ 1.03 B	Britain
BioNTech SE BNTX	1.37 B	$ 102.36	-2.94 %	$ 27.2 B	Germany
Avenue Therapeutics ATXI	1.83 M	-	-52.27 %	$ 4.45 M	USA
Applied Genetic Technologies Corporation AGTC	29.5 M	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	-33.7 M	$ 4.11	0.61 %	$ 439 M	USA
Arcutis Biotherapeutics ARQT	189 M	$ 23.18	-0.34 %	$ 2.95 B	USA
Ayala Pharmaceuticals AYLA	-1.1 M	-	-	$ 7.46 M	Israel
Autolus Therapeutics plc AUTL	178 M	$ 1.43	-0.7 %	$ 381 M	Britain
Aptose Biosciences APTO	-27.2 M	-	-45.71 %	$ 1.2 M	Canada
AstraZeneca PLC AZN	15.6 B	-	-	$ 96.9 B	Britain
Ligand Pharmaceuticals Incorporated LGND	830 M	$ 240.72	4.09 %	$ 4.4 B	USA
AVROBIO AVRO	94.7 M	-	1083.1 %	$ 745 M	USA
Eli Lilly and Company LLY	26.5 B	$ 874.81	-1.06 %	$ 785 B	USA
Can-Fite BioPharma Ltd. CANF	5.59 M	$ 2.9	-0.34 %	$ 4.77 M	Israel
BioDelivery Sciences International BDSI	188 M	-	-4.8 %	$ 255 M	USA